Related Experiment Video
Updated: Jul 4, 2026
07:53
Standardized Rat Coronary Ring Preparation and Real-Time Recording of Dynamic Tension Changes Along Vessel Diameter
Published on: June 16, 2022
Vascular effects of the bufodienolides
1Temple, TX, USA. jpuschett@swmail.sw.org
Summary
Marinobufagenin (MBG), a natriuretic steroid, is linked to preeclampsia development. Increased MBG excretion precedes hypertension and may serve as a diagnostic marker for this condition.
Area of Science:
- Cardiovascular physiology
- Steroid biochemistry
- Reproductive medicine
Background:
- Bufodienolides, like marinobufagenin (MBG), are steroids with natriuretic, vasoconstrictive, and inotropic properties.
- Their mechanism involves inhibiting the Na+/K+ ATPase pump.
- Preeclampsia is a hypertensive disorder of pregnancy often associated with volume expansion.
Purpose of the Study:
- To investigate the role of marinobufagenin (MBG) in a rat model of preeclampsia.
- To determine if MBG excretion levels correlate with preeclampsia development and severity.
- To explore the effects of MBG on placental cytotrophoblast cells.
Main Methods:
- Utilized a rat model of volume expansion-mediated hypertension mimicking preeclampsia.
- Measured urinary excretion of MBG.
- Assessed effects of MBG on human cytotrophoblast cell migration, proliferation, and invasion in vitro.
Main Results:
- Urinary MBG excretion was elevated in the preeclampsia rat model.
- Increased MBG excretion occurred before the onset of hypertension and proteinuria.
- MBG inhibited cytotrophoblast cell migration, proliferation, and invasion.
Conclusions:
- Marinobufagenin (MBG) is implicated as a potential etiological factor in preeclampsia.
- Urinary MBG levels may serve as a valuable diagnostic indicator for preeclampsia.
- MBG's effects on cytotrophoblasts suggest a mechanism for placental dysfunction in preeclampsia.
Related Concept Videos
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...